The landscape of pharmacogenetic testing in a US managed care population.

Heather D AndersonKristy R CrooksDavid P KaoChristina L Aquilante

Published in: Genetics in medicine : official journal of the American College of Medical Genetics (2020)

Pharmacogenetic testing through patients' insurance was low, but more than doubled from 2013 to 2016. This study highlights the need to better understand utilization patterns and insurance coverage for pharmacogenetic tests.

Keyphrases

affordable care act
end stage renal disease
health insurance
healthcare
newly diagnosed
chronic kidney disease
ejection fraction
palliative care
prognostic factors
peritoneal dialysis
long term care
patient reported outcomes
pain management
patient reported